Literature DB >> 226628

Inhibition of the in vitro outgrowth of Epstein-Barr virus-infected lymphocytes by TG lymphocytes.

T C Shope, J Kaplan.   

Abstract

Human T lymphocytes subpopulations from subjects not acutely infected with EBV have been selected and examined for ability to inhibit the outgrowth of autologous B lymphocytes that have undergone in vitro infection with EB virus. The results show that only TG lymphocytes are inhibitory. TG lymphocytes from subjects who are EBV antibody-negative inhibit as well as those from subjects who have EBV antibody. TG lymphocyte populations, as well as other T cell fractions obtained from neonatal subjects, fail to inhibit the outgrowth of infected, autologous lymphocytes under the conditions tested. We propose that NK cells are responsible for the inhibitory effects described in this report.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 226628

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  The effect of leucyl-leucine methyl ester on proliferation and Ig secretion of EBV-transformed human B lymphocytes.

Authors:  M Ohlin; L Danielsson; R Carlsson; C A Borrebaeck
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

2.  Suppressive role of NK cells in pokeweed mitogen-induced immunoglobulin synthesis: effect of depletion/enrichment of Leu 11b+ cells.

Authors:  P D Mason; A P Weetman; J G Sissons; L K Borysiewicz
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

3.  Human newborns are deficient in natural killer activity.

Authors:  J Kaplan; T C Shope; R O Bollinger; J Smith
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

4.  Epstein-Barr virus and rheumatoid arthritis.

Authors:  H G Bluestein; F Hasler
Journal:  Surv Immunol Res       Date:  1984

Review 5.  Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.

Authors:  E Klein; M G Masucci
Journal:  Springer Semin Immunopathol       Date:  1982

6.  Cytotoxic mechanisms in vitro against Epstein-Barr virus infected lymphoblastoid cell lines in rheumatoid arthritis.

Authors:  M B McChesney; A D Bankhurst
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

7.  Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.

Authors:  G R Nemerow; F C Jensen; N R Cooper
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

8.  Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.

Authors:  P C Patel; G Dorval; J Menezes
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

9.  Establishment of long-term monocyte suspension cultures from normal human peripheral blood.

Authors:  S Z Salahuddin; P D Markham; R C Gallo
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.